Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liprotamase in CF-Related Exocrine Pancreatic Insufficiency (DIGEST)
NCT00449878Phase 3Completed
- Sponsor
- Anthera Pharmaceuticals, Inc.
- Start
- May 2007
- Primary completion
- Jun 2008
- Countries
- 1
01
Overview
A Phase 3 trial of liprotamase in exocrine pancreatic insufficiency (EPI), sponsored by Anthera Pharmaceuticals, Inc.. Started May 2007; status: completed.
02
Drugs
liprotamase
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on NCT00449878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00449878.